US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioAtla, Inc.

0.9897

+0.199725.28%

Volume:4.33M

Turnover:4.12M

Market Cap:58.12M

PE:-0.89

High:1.02

Open:0.8890

Low:0.8200

Close:0.7900

52wk High:1.90

52wk Low:0.2400

Shares:58.72M

Float Shares:45.46M

Volume Ratio:2.49

T/O Rate:9.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1086

EPS(LYR):-1.4365

ROE:-813.88%

ROA:-82.52%

PB:-3.47

PE(LYR):-0.69

Loading ...

Overview Company News Filings

BioAtla’s Strategic Advancements and Promising Clinical Data Drive Buy Rating

BioAtla Q3 net loss widens to $15.8 mln

BioAtla Q3 EPS $(0.27) Beats $(0.30) Estimate

BRIEF-BioAtla Q3 Net Income USD -15.778 Million

BioAtla announces data on Mecbotamab Vedotin

BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas

BioAtla to Announce Third Quarter 2025 Financial Results and Provide Business Highlights on November 13, 2025

Bioatla Inc expected to post a loss of 30 cents a share - Earnings Preview

BioAtla announces presentation of poster on Oz-V in OPSCC

BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society

BioAtla Says Cancer Therapy Showed 'Preliminary Prolonged Tumor Control' in Phase 1 Study

MT Newswires Live

BRIEF-BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025

BioAtla announces preliminary data from Phase 1 study of BA3182

Bioatla Presents Promising Interim Data From Its Phase 1 Trial With Ba3182 in Patients With Treatment Refractory Metastatic Adenocarcinoma at Esmo 2025

THOMSON REUTERS

BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025

BioAtla Inc. Granted Continued Nasdaq Listing with Conditions; Must Meet Equity and Bid Price Requirements by Early 2026

BRIEF-BioAtla Updates FDA on Ozuriftamab Vedotin Plan for OPSCC After Positive Phase 2 Results

BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Following Productive Type B (End of Phase 2) Meeting with FDA

Bioatla Inc reports results for the quarter ended June 30 - Earnings Summary

BioAtla Q2 EPS $(0.32) Misses $(0.29) Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BCAB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAB\",,,,,undefined,":{"symbol":"BCAB","market":"US","secType":"STK","nameCN":"BioAtla, Inc.","latestPrice":0.9897,"timestamp":1763412537859,"preClose":0.79,"halted":0,"volume":4328922,"delay":0,"floatShares":45455917,"shares":58721588,"eps":-1.108564,"marketStatus":"Trading","change":0.1997,"latestTime":"11-17 15:49:05 EST","open":0.889,"high":1.0199,"low":0.82,"amount":4119244.169547,"amplitude":0.253038,"askPrice":0.9938,"askSize":14928,"bidPrice":0.9896,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-1.108564,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1763413200000},"marketStatusCode":2,"adr":0,"listingDate":1608094800000,"exchange":"NASDAQ","adjPreClose":0.79,"preHourTrading":{"tag":"盘前","latestPrice":0.8801,"preClose":0.79,"latestTime":"09:29 EST","volume":117477,"amount":101566.51777701,"timestamp":1763389791590},"postHourTrading":{"tag":"盘后","latestPrice":0.86,"preClose":0.79,"latestTime":"19:59 EST","volume":94243,"amount":77536.280422,"timestamp":1763168391768},"volumeRatio":2.494909,"impliedVol":1.5462,"impliedVolPercentile":0.308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAB\",,,,,undefined,":{"symbol":"BCAB","floatShares":45455917,"roa":"-82.52%","roe":"-813.88%","lyrEps":-1.436507,"volumeRatio":2.494909,"shares":58721588,"dividePrice":0,"high":1.0199,"amplitude":0.253038,"preClose":0.79,"low":0.82,"week52Low":0.24,"pbRate":"-3.47","psRate":"5.28","week52High":1.9,"institutionHeld":0,"latestPrice":0.9897,"committee":-0.947808,"eps":-1.108564,"divideRate":0,"volume":4328922,"delay":0,"ttmEps":-1.108564,"open":0.889,"prevYearClose":0.5912,"prevWeekClose":0.79,"prevMonthClose":0.6994,"prevQuarterClose":0.6879,"fiveDayClose":0.6387,"twentyDayClose":0.614,"sixtyDayClose":0.3562},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"BCAB","fiscalQuarterEnding":"2025/09","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-08-07","symbol":"BCAB","fiscalQuarterEnding":"2025/06","expectedEps":-0.29,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-05-06","symbol":"BCAB","fiscalQuarterEnding":"2025/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2025-03-27","symbol":"BCAB","fiscalQuarterEnding":"2024/12","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-11-07","symbol":"BCAB","fiscalQuarterEnding":"2024/09","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":3,"updateTime":1755234000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCAB","date":"2025-11-14","current":-0.856965,"percent":0.799505,"low":-114.659072,"twenty":-9.894892,"median":-1.265267,"eighty":-0.648893,"high":-0.216236,"avg":-9.079316,"sd":19.378353,"marketCap":38738631},"quantilePoints":[{"date":"2020-12-18","current":-53.945995,"twenty":-53.995317,"median":-47.811564,"eighty":-27.743654,"marketCap":1123101665},{"date":"2020-12-24","current":-49.044616,"twenty":-52.466333,"median":-49.599489,"eighty":-39.7844,"marketCap":1021059856},{"date":"2020-12-31","current":-54.99302,"twenty":-54.850727,"median":-51.479892,"eighty":-48.304785,"marketCap":1144899682},{"date":"2021-01-08","current":-61.848957,"twenty":-55.917925,"median":-54.0693,"eighty":-49.266565,"marketCap":1287633426},{"date":"2021-01-15","current":-73.377925,"twenty":-63.740807,"median":-54.637287,"eighty":-49.673472,"marketCap":1527655030},{"date":"2021-01-22","current":-74.089391,"twenty":-70.292754,"median":-55.413431,"eighty":-50.123536,"marketCap":1542467022},{"date":"2021-01-29","current":-71.098003,"twenty":-72.132861,"median":-60.04604,"eighty":-51.665088,"marketCap":1480189327},{"date":"2021-02-05","current":-77.371832,"twenty":-73.688383,"median":-65.002041,"eighty":-52.713898,"marketCap":1610804169},{"date":"2021-02-12","current":-81.672962,"twenty":-75.179226,"median":-69.877194,"eighty":-53.995317,"marketCap":1700349395},{"date":"2021-02-19","current":-89.272703,"twenty":-77.371832,"median":-70.782695,"eighty":-54.192605,"marketCap":1858568404},{"date":"2021-02-26","current":-85.860904,"twenty":-81.672962,"median":-71.971165,"eighty":-54.604948,"marketCap":1787538168},{"date":"2021-03-05","current":-78.244994,"twenty":-83.160571,"median":-72.93326,"eighty":-54.637287,"marketCap":1628982523},{"date":"2021-03-12","current":-107.382724,"twenty":-85.683038,"median":-74.089391,"eighty":-54.99302,"marketCap":2235600937},{"date":"2021-03-19","current":-109.953701,"twenty":-87.364683,"median":-75.116164,"eighty":-55.413431,"marketCap":2289126092},{"date":"2021-03-26","current":-53.866673,"twenty":-87.364683,"median":-75.011061,"eighty":-55.413431,"marketCap":1931281822},{"date":"2021-04-01","current":-47.970164,"twenty":-87.364683,"median":-74.089391,"eighty":-54.522479,"marketCap":1719874294},{"date":"2021-04-09","current":-44.458549,"twenty":-86.278081,"median":-72.93326,"eighty":-52.220678,"marketCap":1593972359},{"date":"2021-04-16","current":-44.824734,"twenty":-85.890009,"median":-71.971165,"eighty":-49.040047,"marketCap":1607101171},{"date":"2021-04-23","current":-47.359857,"twenty":-85.731547,"median":-70.782695,"eighty":-47.722285,"marketCap":1697992942},{"date":"2021-04-30","current":-46.561762,"twenty":-85.686272,"median":-69.464867,"eighty":-47.722285,"marketCap":1669378866},{"date":"2021-05-07","current":-43.951524,"twenty":-85.178544,"median":-63.425499,"eighty":-46.426556,"marketCap":1575794005},{"date":"2021-05-14","current":-28.81911,"twenty":-84.664349,"median":-60.260817,"eighty":-45.228475,"marketCap":1525971849},{"date":"2021-05-21","current":-27.000829,"twenty":-83.985224,"median":-56.637873,"eighty":-44.61629,"marketCap":1429693898},{"date":"2021-05-28","current":-27.369571,"twenty":-83.296396,"median":-54.99302,"eighty":-43.98157,"marketCap":1449218797},{"date":"2021-06-04","current":-26.511292,"twenty":-82.626972,"median":-54.604948,"eighty":-43.213522,"marketCap":1403772912},{"date":"2021-06-11","current":-31.629179,"twenty":-81.912273,"median":-53.906334,"eighty":-42.698986,"marketCap":1674765045},{"date":"2021-06-18","current":-25.144403,"twenty":-81.381908,"median":-52.405874,"eighty":-29.957124,"marketCap":1331396131},{"date":"2021-06-25","current":-27.178843,"twenty":-81.168469,"median":-50.650822,"eighty":-28.803852,"marketCap":1439119712},{"date":"2021-07-02","current":-27.757386,"twenty":-80.777163,"median":-49.599489,"eighty":-27.787903,"marketCap":1469753605},{"date":"2021-07-09","current":-26.702021,"twenty":-80.486109,"median":-49.021771,"eighty":-27.743654,"marketCap":1413871998},{"date":"2021-07-16","current":-24.845595,"twenty":-79.554736,"median":-47.890864,"eighty":-27.252591,"marketCap":1315574230},{"date":"2021-07-23","current":-26.237914,"twenty":-77.895729,"median":-47.669705,"eighty":-26.848246,"marketCap":1389297556},{"date":"2021-07-30","current":-26.059901,"twenty":-77.151924,"median":-46.918558,"eighty":-26.52655,"marketCap":1379871742},{"date":"2021-08-06","current":-26.212484,"twenty":-76.608624,"median":-45.557102,"eighty":-26.296404,"marketCap":1387951011},{"date":"2021-08-13","current":-18.067947,"twenty":-75.861586,"median":-45.143971,"eighty":-26.293861,"marketCap":1393201305},{"date":"2021-08-20","current":-17.971491,"twenty":-75.137185,"median":-44.749619,"eighty":-26.166709,"marketCap":1385763686},{"date":"2021-08-27","current":-17.914494,"twenty":-74.98519,"median":-44.341182,"eighty":-25.800509,"marketCap":1381368729},{"date":"2021-09-03","current":-18.028488,"twenty":-74.603586,"median":-43.989082,"eighty":-25.504244,"marketCap":1390158643},{"date":"2021-09-10","current":-16.621108,"twenty":-74.024712,"median":-43.838852,"eighty":-25.415238,"marketCap":1281637017},{"date":"2021-09-17","current":-15.147963,"twenty":-73.688383,"median":-43.190987,"eighty":-25.277913,"marketCap":1168044288},{"date":"2021-09-24","current":-13.376682,"twenty":-73.200059,"median":-42.72152,"eighty":-24.981648,"marketCap":1031462553},{"date":"2021-10-01","current":-13.543287,"twenty":-72.46919,"median":-32.02653,"eighty":-24.846866,"marketCap":1044309350},{"date":"2021-10-08","current":-11.763237,"twenty":-72.307494,"median":-29.117918,"eighty":-24.242892,"marketCap":907051468},{"date":"2021-10-15","current":-12.42966,"twenty":-71.796533,"median":-28.930368,"eighty":-18.407296,"marketCap":958438656},{"date":"2021-10-22","current":-13.572363,"twenty":-71.091535,"median":-28.780964,"eighty":-18.03638,"marketCap":1046551354},{"date":"2021-10-29","current":-13.905369,"twenty":-70.952476,"median":-27.782817,"eighty":-17.893449,"marketCap":1072229095},{"date":"2021-11-05","current":-14.642739,"twenty":-70.457685,"median":-27.743654,"eighty":-17.404155,"marketCap":1129086949},{"date":"2021-11-12","current":-13.272658,"twenty":-70.124589,"median":-27.429969,"eighty":-16.621108,"marketCap":1023441387},{"date":"2021-11-19","current":-11.404043,"twenty":-68.779273,"median":-27.178843,"eighty":-16.18881,"marketCap":1008197187},{"date":"2021-11-26","current":-10.254055,"twenty":-66.036899,"median":-26.975399,"eighty":-14.723612,"marketCap":906530243},{"date":"2021-12-03","current":-9.374898,"twenty":-65.002041,"median":-26.86414,"eighty":-14.176531,"marketCap":828806602},{"date":"2021-12-10","current":-8.791571,"twenty":-61.848957,"median":-26.632087,"eighty":-13.80071,"marketCap":777236413},{"date":"2021-12-17","current":-8.29991,"twenty":-61.169831,"median":-26.574869,"eighty":-13.701124,"marketCap":733770112},{"date":"2021-12-23","current":-8.358242,"twenty":-60.44262,"median":-26.457252,"eighty":-13.659044,"marketCap":738927130},{"date":"2021-12-31","current":-8.179078,"twenty":-59.189962,"median":-26.307848,"eighty":-13.534831,"marketCap":723087715},{"date":"2022-01-07","current":-6.716594,"twenty":-57.401644,"median":-26.266523,"eighty":-13.310716,"marketCap":593793885},{"date":"2022-01-14","current":-5.262443,"twenty":-56.407702,"median":-26.212484,"eighty":-12.820745,"marketCap":465236772},{"date":"2022-01-21","current":-4.195788,"twenty":-55.74976,"median":-26.059901,"eighty":-12.445444,"marketCap":370936999},{"date":"2022-01-28","current":-3.762459,"twenty":-55.161184,"median":-25.802416,"eighty":-12.110479,"marketCap":332627716},{"date":"2022-02-04","current":-3.429129,"twenty":-54.77958,"median":-25.65937,"eighty":-11.700102,"marketCap":303159037},{"date":"2022-02-11","current":-2.991634,"twenty":-54.617884,"median":-25.44639,"eighty":-11.411542,"marketCap":264481395},{"date":"2022-02-18","current":-2.812469,"twenty":-54.357542,"median":-25.411423,"eighty":-10.644884,"marketCap":248641980},{"date":"2022-02-25","current":-2.766637,"twenty":-54.093961,"median":-25.405065,"eighty":-10.056557,"marketCap":244590037},{"date":"2022-03-04","current":-2.151596,"twenty":-53.914266,"median":-25.227052,"eighty":-9.456564,"marketCap":205266523},{"date":"2022-03-11","current":-2.026412,"twenty":-53.415984,"median":-25.144403,"eighty":-8.963236,"marketCap":193323743},{"date":"2022-03-18","current":-2.257219,"twenty":-52.60632,"median":-24.871025,"eighty":-8.522407,"marketCap":215343243},{"date":"2022-03-25","current":-1.74866,"twenty":-52.035481,"median":-24.845595,"eighty":-8.26991,"marketCap":166825701},{"date":"2022-04-01","current":-1.967732,"twenty":-51.221501,"median":-24.451422,"eighty":-8.114912,"marketCap":187725565},{"date":"2022-04-08","current":-1.842548,"twenty":-50.68744,"median":-24.025461,"eighty":-7.687417,"marketCap":175782786},{"date":"2022-04-14","current":-1.564797,"twenty":-50.331073,"median":-18.414311,"eighty":-6.71326,"marketCap":149284744},{"date":"2022-04-22","current":-1.439613,"twenty":-49.747455,"median":-18.249898,"eighty":-5.433275,"marketCap":137341964},{"date":"2022-04-29","current":-1.363641,"twenty":-49.488514,"median":-18.028488,"eighty":-4.27162,"marketCap":130094033},{"date":"2022-05-06","current":-0.807908,"twenty":-49.040047,"median":-17.942993,"eighty":-4.02579,"marketCap":81562354},{"date":"2022-05-13","current":-0.85238,"twenty":-48.833984,"median":-17.83996,"eighty":-3.695793,"marketCap":86052025},{"date":"2022-05-20","current":-0.856086,"twenty":-48.060302,"median":-17.454136,"eighty":-3.362463,"marketCap":86426164},{"date":"2022-05-27","current":-0.904264,"twenty":-47.938444,"median":-16.866632,"eighty":-2.998301,"marketCap":91289974},{"date":"2022-06-03","current":-1.01915,"twenty":-47.811564,"median":-16.621108,"eighty":-2.858302,"marketCap":102888291},{"date":"2022-06-10","current":-1.09327,"twenty":-47.73543,"median":-16.347085,"eighty":-2.76247,"marketCap":110371075},{"date":"2022-06-17","current":-0.967266,"twenty":-47.669705,"median":-16.077447,"eighty":-2.534971,"marketCap":97650341},{"date":"2022-06-24","current":-1.31563,"twenty":-47.421827,"median":-14.723612,"eighty":-2.313552,"marketCap":132819430},{"date":"2022-07-01","current":-1.089564,"twenty":-47.292254,"median":-14.326384,"eighty":-2.193062,"marketCap":109996936},{"date":"2022-07-08","current":-1.471282,"twenty":-46.847198,"median":-14.160238,"eighty":-2.129689,"marketCap":148533278},{"date":"2022-07-15","current":-1.560226,"twenty":-46.156143,"median":-13.905369,"eighty":-2.067879,"marketCap":157512620},{"date":"2022-07-22","current":-1.40828,"twenty":-45.688553,"median":-13.767409,"eighty":-1.966167,"marketCap":142172911},{"date":"2022-07-29","current":-1.26004,"twenty":-45.450064,"median":-13.701124,"eighty":-1.919223,"marketCap":127207341},{"date":"2022-08-05","current":-1.460164,"twenty":-45.322369,"median":-13.684158,"eighty":-1.794039,"marketCap":147410860},{"date":"2022-08-12","current":-2.636083,"twenty":-45.115803,"median":-13.572363,"eighty":-1.774479,"marketCap":262237545},{"date":"2022-08-19","current":-3.544947,"twenty":-44.896093,"median":-13.522146,"eighty":-1.794039,"marketCap":352651349},{"date":"2022-08-26","current":-3.424268,"twenty":-44.779665,"median":-13.324069,"eighty":-1.821423,"marketCap":340646197},{"date":"2022-09-02","current":-3.005663,"twenty":-44.693283,"median":-13.173409,"eighty":-1.840983,"marketCap":299003324},{"date":"2022-09-09","current":-3.33753,"twenty":-44.576855,"median":-12.894402,"eighty":-1.872279,"marketCap":332017493},{"date":"2022-09-16","current":-3.160283,"twenty":-44.364655,"median":-12.482272,"eighty":-1.918441,"marketCap":314384926},{"date":"2022-09-23","current":-3.020748,"twenty":-44.216304,"median":-12.403354,"eighty":-1.931742,"marketCap":300503969},{"date":"2022-09-30","current":-2.90384,"twenty":-44.118655,"median":-12.15783,"eighty":-1.951302,"marketCap":288873977},{"date":"2022-10-07","current":-3.103714,"twenty":-43.974059,"median":-11.854332,"eighty":-1.959126,"marketCap":308757511},{"date":"2022-10-14","current":-2.598371,"twenty":-43.906455,"median":-11.6054,"eighty":-1.965385,"marketCap":258485935},{"date":"2022-10-21","current":-2.56443,"twenty":-43.594729,"median":-11.482473,"eighty":-1.988074,"marketCap":255109486},{"date":"2022-10-28","current":-2.604028,"twenty":-43.213522,"median":-11.324877,"eighty":-2.021718,"marketCap":259048677},{"date":"2022-11-04","current":-2.774728,"twenty":-43.190987,"median":-10.629051,"eighty":-2.027977,"marketCap":283935092},{"date":"2022-11-11","current":-4.155467,"twenty":-43.149674,"median":-10.254055,"eighty":-2.055361,"marketCap":425224776},{"date":"2022-11-18","current":-3.914839,"twenty":-42.941231,"median":-9.801977,"eighty":-2.09761,"marketCap":400601515},{"date":"2022-11-25","current":-4.595076,"twenty":-42.710253,"median":-9.47698,"eighty":-2.107782,"marketCap":470209580},{"date":"2022-12-02","current":-4.868097,"twenty":-40.616924,"median":-9.087401,"eighty":-2.1203,"marketCap":498147511},{"date":"2022-12-09","current":-4.400723,"twenty":-32.264941,"median":-8.837404,"eighty":-2.12343,"marketCap":450321561},{"date":"2022-12-16","current":-4.072173,"twenty":-31.406662,"median":-8.649906,"eighty":-2.139078,"marketCap":416701340},{"date":"2022-12-23","current":-3.850054,"twenty":-30.23686,"median":-8.339493,"eighty":-2.155508,"marketCap":393972176},{"date":"2022-12-30","current":-3.817662,"twenty":-29.117918,"median":-8.27491,"eighty":-2.171156,"marketCap":390657506},{"date":"2023-01-06","current":-3.808407,"twenty":-29.051799,"median":-8.166578,"eighty":-2.193062,"marketCap":389710457},{"date":"2023-01-13","current":-1.601104,"twenty":-28.989494,"median":-8.108245,"eighty":-2.132818,"marketCap":163839390},{"date":"2023-01-20","current":-1.610359,"twenty":-28.920832,"median":-7.91658,"eighty":-2.099958,"marketCap":164786439},{"date":"2023-01-27","current":-1.702909,"twenty":-28.84454,"median":-7.458253,"eighty":-1.998246,"marketCap":174256924},{"date":"2023-02-03","current":-1.975929,"twenty":-28.796222,"median":-6.712427,"eighty":-1.959627,"marketCap":202194854},{"date":"2023-02-10","current":-1.689026,"twenty":-28.433838,"median":-5.952018,"eighty":-1.91899,"marketCap":172836351},{"date":"2023-02-17","current":-1.721418,"twenty":-27.965916,"median":-5.262443,"eighty":-1.873199,"marketCap":176151021},{"date":"2023-02-24","current":-1.328084,"twenty":-27.787903,"median":-4.988411,"eighty":-1.832164,"marketCap":135901459},{"date":"2023-03-03","current":-1.374358,"twenty":-27.757386,"median":-4.842646,"eighty":-1.78065,"marketCap":140636702},{"date":"2023-03-10","current":-1.110593,"twenty":-27.751893,"median":-4.595076,"eighty":-1.72762,"marketCap":113645820},{"date":"2023-03-17","current":-1.15224,"twenty":-27.743654,"median":-4.546488,"eighty":-1.702909,"marketCap":117907538},{"date":"2023-03-24","current":-1.055135,"twenty":-27.642339,"median":-4.508284,"eighty":-1.66774,"marketCap":112352833},{"date":"2023-03-31","current":-1.198204,"twenty":-27.442048,"median":-4.400723,"eighty":-1.622487,"marketCap":127587116},{"date":"2023-04-06","current":-1.345744,"twenty":-27.3683,"median":-4.333624,"eighty":-1.601823,"marketCap":143297470},{"date":"2023-04-14","current":-1.596114,"twenty":-27.32634,"median":-4.212454,"eighty":-1.592968,"marketCap":169957464},{"date":"2023-04-21","current":-1.564818,"twenty":-27.14324,"median":-4.199955,"eighty":-1.592968,"marketCap":166624965},{"date":"2023-04-28","current":-1.543442,"twenty":-26.995743,"median":-4.155467,"eighty":-1.573681,"marketCap":164348757},{"date":"2023-05-05","current":-1.628443,"twenty":-26.970313,"median":-4.102251,"eighty":-1.573681,"marketCap":173399848},{"date":"2023-05-12","current":-1.436072,"twenty":-26.948696,"median":-4.072173,"eighty":-1.564105,"marketCap":152915800},{"date":"2023-05-19","current":-1.427574,"twenty":-26.911822,"median":-3.968707,"eighty":-1.557624,"marketCap":156587790},{"date":"2023-05-26","current":-1.303721,"twenty":-26.76814,"median":-3.866625,"eighty":-1.548613,"marketCap":143002548},{"date":"2023-06-02","current":-1.442785,"twenty":-26.702021,"median":-3.859309,"eighty":-1.534494,"marketCap":158256153},{"date":"2023-06-09","current":-1.607923,"twenty":-26.632087,"median":-3.841837,"eighty":-1.534494,"marketCap":176369809},{"date":"2023-06-16","current":-1.625305,"twenty":-26.625729,"median":-3.822289,"eighty":-1.542736,"marketCap":178276509},{"date":"2023-06-23","current":-1.616614,"twenty":-26.605385,"median":-3.817662,"eighty":-1.543301,"marketCap":177323159},{"date":"2023-06-30","current":-1.281992,"twenty":-26.569782,"median":-3.808407,"eighty":-1.529157,"marketCap":140619172},{"date":"2023-07-07","current":-1.18204,"twenty":-26.53418,"median":-3.76676,"eighty":-1.515678,"marketCap":129655643},{"date":"2023-07-14","current":-1.216806,"twenty":-26.46806,"median":-3.74825,"eighty":-1.506731,"marketCap":133469044},{"date":"2023-07-21","current":-1.299375,"twenty":-26.387954,"median":-3.734367,"eighty":-1.491341,"marketCap":142525872},{"date":"2023-07-28","current":-1.212461,"twenty":-26.342179,"median":-3.662641,"eighty":-1.481445,"marketCap":132992369},{"date":"2023-08-04","current":-1.230627,"twenty":-26.305305,"median":-3.572406,"eighty":-1.469828,"marketCap":143409918},{"date":"2023-08-11","current":-1.111667,"twenty":-26.296404,"median":-3.506671,"eighty":-1.457987,"marketCap":129546959},{"date":"2023-08-18","current":-1.029625,"twenty":-26.270974,"median":-3.445796,"eighty":-1.444634,"marketCap":119986298},{"date":"2023-08-25","current":-1.013216,"twenty":-26.241729,"median":-3.420497,"eighty":-1.440421,"marketCap":118074165},{"date":"2023-09-01","current":-1.029625,"twenty":-26.227742,"median":-3.379014,"eighty":-1.409762,"marketCap":119986298},{"date":"2023-09-08","current":-1.00091,"twenty":-26.197226,"median":-3.33753,"eighty":-1.388334,"marketCap":116640066},{"date":"2023-09-15","current":-0.845031,"twenty":-26.120934,"median":-3.288182,"eighty":-1.378986,"marketCap":98474810},{"date":"2023-09-22","current":-0.808112,"twenty":-26.015398,"median":-3.265877,"eighty":-1.374472,"marketCap":94172512},{"date":"2023-09-29","current":-0.734274,"twenty":-25.832298,"median":-3.222595,"eighty":-1.351469,"marketCap":85567917},{"date":"2023-10-06","current":-0.72607,"twenty":-25.808138,"median":-3.167825,"eighty":-1.343076,"marketCap":84611851},{"date":"2023-10-13","current":-0.709662,"twenty":-25.771264,"median":-3.150855,"eighty":-1.329295,"marketCap":82699719},{"date":"2023-10-20","current":-0.676845,"twenty":-25.679715,"median":-3.118799,"eighty":-1.315856,"marketCap":78875454},{"date":"2023-10-27","current":-0.545578,"twenty":-25.669542,"median":-3.103714,"eighty":-1.304196,"marketCap":63578396},{"date":"2023-11-03","current":-0.668641,"twenty":-25.609781,"median":-3.099943,"eighty":-1.293292,"marketCap":77919388},{"date":"2023-11-10","current":-0.565973,"twenty":-25.504244,"median":-3.047146,"eighty":-1.280254,"marketCap":70225958},{"date":"2023-11-17","current":-0.579495,"twenty":-25.444483,"median":-3.020748,"eighty":-1.276534,"marketCap":71903712},{"date":"2023-11-24","current":-0.614264,"twenty":-25.434311,"median":-3.013205,"eighty":-1.266742,"marketCap":76217934},{"date":"2023-12-01","current":-0.683804,"twenty":-25.422867,"median":-2.99812,"eighty":-1.257567,"marketCap":84846380},{"date":"2023-12-08","current":-0.598811,"twenty":-25.40888,"median":-2.948148,"eighty":-1.236292,"marketCap":74300502},{"date":"2023-12-15","current":-0.768796,"twenty":-25.405065,"median":-2.90384,"eighty":-1.214199,"marketCap":95392257},{"date":"2023-12-22","current":-0.869242,"twenty":-25.394893,"median":-2.854673,"eighty":-1.198204,"marketCap":107855568},{"date":"2023-12-29","current":-1.085587,"twenty":-25.379635,"median":-2.839729,"eighty":-1.184632,"marketCap":134699620},{"date":"2024-01-05","current":-0.92526,"twenty":-25.303343,"median":-2.820873,"eighty":-1.178181,"marketCap":114806260},{"date":"2024-01-12","current":-0.931055,"twenty":-25.221965,"median":-2.77497,"eighty":-1.140212,"marketCap":115525297},{"date":"2024-01-19","current":-0.803566,"twenty":-25.18382,"median":-2.766637,"eighty":-1.129466,"marketCap":99706480},{"date":"2024-01-26","current":-0.822883,"twenty":-25.152032,"median":-2.75545,"eighty":-1.122486,"marketCap":102103271},{"date":"2024-02-02","current":-0.7263,"twenty":-25.063025,"median":-2.641638,"eighty":-1.112382,"marketCap":90119319},{"date":"2024-02-09","current":-1.12422,"twenty":-24.918071,"median":-2.616284,"eighty":-1.104646,"marketCap":139493201},{"date":"2024-02-16","current":-1.023774,"twenty":-24.873568,"median":-2.598371,"eighty":-1.092002,"marketCap":127029891},{"date":"2024-02-23","current":-0.911738,"twenty":-24.857038,"median":-2.590828,"eighty":-1.086382,"marketCap":113128506},{"date":"2024-03-01","current":-1.043091,"twenty":-24.850681,"median":-2.55123,"eighty":-1.079425,"marketCap":129426681},{"date":"2024-03-08","current":-1.097177,"twenty":-24.803635,"median":-2.523235,"eighty":-1.07885,"marketCap":136137694},{"date":"2024-03-15","current":-0.921397,"twenty":-24.609091,"median":-2.492777,"eighty":-1.074748,"marketCap":114326902},{"date":"2024-03-22","current":-0.931055,"twenty":-24.481939,"median":-2.432437,"eighty":-1.070134,"marketCap":115525297},{"date":"2024-03-28","current":-1.347902,"twenty":-24.400561,"median":-2.372098,"eighty":-1.070134,"marketCap":166414640},{"date":"2024-04-05","current":-1.527103,"twenty":-24.203475,"median":-2.292427,"eighty":-1.070134,"marketCap":188539130},{"date":"2024-04-12","current":-1.305049,"twenty":-24.025461,"median":-2.206363,"eighty":-1.070134,"marketCap":161124001},{"date":"2024-04-19","current":-0.946648,"twenty":-18.414311,"median":-2.161376,"eighty":-1.070134,"marketCap":116875022},{"date":"2024-04-26","current":-0.876701,"twenty":-18.414311,"median":-2.1203,"eighty":-1.055135,"marketCap":108239213},{"date":"2024-05-03","current":-1.231277,"twenty":-18.405542,"median":-2.098784,"eighty":-1.050664,"marketCap":152015961},{"date":"2024-05-10","current":-1.133866,"twenty":-18.260859,"median":-2.026412,"eighty":-1.054237,"marketCap":139989382},{"date":"2024-05-17","current":-1.250959,"twenty":-18.238937,"median":-1.971831,"eighty":-1.053227,"marketCap":149159345},{"date":"2024-05-24","current":-0.847424,"twenty":-18.067947,"median":-1.962047,"eighty":-1.046033,"marketCap":101043427},{"date":"2024-05-31","current":-0.611356,"twenty":-18.03638,"median":-1.948172,"eighty":-1.04029,"marketCap":72895615},{"date":"2024-06-07","current":-0.665833,"twenty":-18.017965,"median":-1.918638,"eighty":-1.029625,"marketCap":79391264},{"date":"2024-06-14","current":-0.63355,"twenty":-17.989028,"median":-1.904203,"eighty":-1.026495,"marketCap":75541991},{"date":"2024-06-21","current":-0.571002,"twenty":-17.948692,"median":-1.869498,"eighty":-1.020535,"marketCap":68084023},{"date":"2024-06-28","current":-0.593197,"twenty":-17.925893,"median":-1.846768,"eighty":-1.017963,"marketCap":70730399},{"date":"2024-07-05","current":-0.577055,"twenty":-17.89871,"median":-1.833243,"eighty":-1.000784,"marketCap":68805762},{"date":"2024-07-12","current":-0.645656,"twenty":-17.859251,"median":-1.791692,"eighty":-0.993208,"marketCap":76985468},{"date":"2024-07-15","current":-0.726363,"twenty":-17.849606,"median":-1.788947,"eighty":-0.992702,"marketCap":86608652},{"date":"2024-08-02","current":-0.706187,"twenty":-17.83996,"median":-1.786203,"eighty":-0.990679,"marketCap":84202856},{"date":"2024-08-09","current":-0.593197,"twenty":-17.743504,"median":-1.751235,"eighty":-0.985604,"marketCap":70730399},{"date":"2024-08-16","current":-0.869115,"twenty":-17.537439,"median":-1.721418,"eighty":-0.9804,"marketCap":90871185},{"date":"2024-08-23","current":-0.832131,"twenty":-17.370834,"median":-1.710025,"eighty":-0.958098,"marketCap":87004326},{"date":"2024-08-30","current":-0.841377,"twenty":-16.879785,"median":-1.702909,"eighty":-0.946648,"marketCap":87971041},{"date":"2024-09-06","current":-0.855246,"twenty":-16.869263,"median":-1.689026,"eighty":-0.938401,"marketCap":89421113},{"date":"2024-09-13","current":-0.799771,"twenty":-16.670213,"median":-1.674162,"eighty":-0.931055,"marketCap":83620825},{"date":"2024-09-20","current":-0.804394,"twenty":-16.621108,"median":-1.668763,"eighty":-0.92113,"marketCap":84104182},{"date":"2024-09-27","current":-0.753541,"twenty":-16.557974,"median":-1.658352,"eighty":-0.918403,"marketCap":78787251},{"date":"2024-10-04","current":-1.086394,"twenty":-16.422935,"median":-1.647034,"eighty":-0.914829,"marketCap":113588981},{"date":"2024-10-11","current":-0.89223,"twenty":-16.319464,"median":-1.63122,"eighty":-0.914829,"marketCap":93287972},{"date":"2024-10-18","current":-0.855246,"twenty":-16.18881,"median":-1.625305,"eighty":-0.906469,"marketCap":89421113},{"date":"2024-10-25","current":-0.882984,"twenty":-16.094108,"median":-1.618068,"eighty":-0.901476,"marketCap":92321257},{"date":"2024-10-31","current":-0.933836,"twenty":-15.519757,"median":-1.611408,"eighty":-0.902998,"marketCap":97638188},{"date":"2024-11-08","current":-1.026295,"twenty":-14.893352,"median":-1.609527,"eighty":-0.904163,"marketCap":107305336},{"date":"2024-11-15","current":-1.010437,"twenty":-14.675088,"median":-1.60631,"eighty":-0.905365,"marketCap":82670929},{"date":"2024-11-22","current":-0.821349,"twenty":-14.500022,"median":-1.597127,"eighty":-0.901476,"marketCap":67200346},{"date":"2024-11-29","current":-0.99271,"twenty":-14.342082,"median":-1.596477,"eighty":-0.90249,"marketCap":81220562},{"date":"2024-12-06","current":-0.921802,"twenty":-14.219346,"median":-1.593533,"eighty":-0.904113,"marketCap":75419093},{"date":"2024-12-13","current":-0.844985,"twenty":-14.163497,"median":-1.586194,"eighty":-0.904037,"marketCap":69134169},{"date":"2024-12-20","current":-0.70317,"twenty":-14.063273,"median":-1.576903,"eighty":-0.898171,"marketCap":57531231},{"date":"2024-12-27","current":-0.378175,"twenty":-13.934885,"median":-1.569079,"eighty":-0.892567,"marketCap":30941166},{"date":"2025-01-03","current":-0.362812,"twenty":-13.905369,"median":-1.564364,"eighty":-0.89223,"marketCap":29684181},{"date":"2025-01-10","current":-0.330903,"twenty":-13.821642,"median":-1.558599,"eighty":-0.885734,"marketCap":27073520},{"date":"2025-01-17","current":-0.287118,"twenty":-13.781681,"median":-1.551428,"eighty":-0.878361,"marketCap":23491113},{"date":"2025-01-24","current":-0.350771,"twenty":-13.765507,"median":-1.551405,"eighty":-0.875867,"marketCap":28699031},{"date":"2025-01-31","current":-0.336161,"twenty":-13.755041,"median":-1.545189,"eighty":-0.873738,"marketCap":27503722},{"date":"2025-02-07","current":-0.354601,"twenty":-13.72193,"median":-1.534494,"eighty":-0.869242,"marketCap":29012365},{"date":"2025-02-14","current":-0.309212,"twenty":-13.695863,"median":-1.526229,"eighty":-0.862705,"marketCap":25298782},{"date":"2025-02-21","current":-0.318148,"twenty":-13.691931,"median":-1.521008,"eighty":-0.856086,"marketCap":26029894},{"date":"2025-02-28","current":-0.222193,"twenty":-13.685585,"median":-1.510812,"eighty":-0.852722,"marketCap":18179148},{"date":"2025-03-07","current":-0.233327,"twenty":-13.641066,"median":-1.506884,"eighty":-0.849524,"marketCap":19090136},{"date":"2025-03-14","current":-0.229923,"twenty":-13.581224,"median":-1.500788,"eighty":-0.845003,"marketCap":18811617},{"date":"2025-03-21","current":-0.254603,"twenty":-13.560733,"median":-1.491043,"eighty":-0.839506,"marketCap":20830878},{"date":"2025-03-28","current":-0.278432,"twenty":-13.543287,"median":-1.482645,"eighty":-0.83398,"marketCap":22780509},{"date":"2025-04-04","current":-0.25101,"twenty":-13.526374,"median":-1.480581,"eighty":-0.827508,"marketCap":17514503},{"date":"2025-04-11","current":-0.246742,"twenty":-13.451276,"median":-1.471535,"eighty":-0.821963,"marketCap":17216658},{"date":"2025-04-17","current":-0.263733,"twenty":-13.366159,"median":-1.468859,"eighty":-0.819228,"marketCap":18402201},{"date":"2025-04-25","current":-0.381914,"twenty":-13.323301,"median":-1.459303,"eighty":-0.815189,"marketCap":26648443},{"date":"2025-05-02","current":-0.416063,"twenty":-13.310716,"median":-1.453967,"eighty":-0.807949,"marketCap":29031210},{"date":"2025-05-09","current":-0.446437,"twenty":-13.232959,"median":-1.44485,"eighty":-0.803693,"marketCap":27623742},{"date":"2025-05-16","current":-0.404743,"twenty":-13.04084,"median":-1.442011,"eighty":-0.798125,"marketCap":25043857},{"date":"2025-05-23","current":-0.384161,"twenty":-12.902294,"median":-1.440505,"eighty":-0.795286,"marketCap":23770341},{"date":"2025-05-30","current":-0.369149,"twenty":-12.881249,"median":-1.431823,"eighty":-0.780386,"marketCap":22841493},{"date":"2025-06-06","current":-0.431178,"twenty":-12.578728,"median":-1.40828,"eighty":-0.774078,"marketCap":26679565},{"date":"2025-06-13","current":-0.404365,"twenty":-12.482272,"median":-1.398963,"eighty":-0.768796,"marketCap":25020490},{"date":"2025-06-20","current":-0.37623,"twenty":-12.461227,"median":-1.388399,"eighty":-0.766479,"marketCap":23279629},{"date":"2025-06-27","current":-0.354138,"twenty":-12.434921,"median":-1.379315,"eighty":-0.754536,"marketCap":21912645},{"date":"2025-07-03","current":-0.355082,"twenty":-12.398093,"median":-1.378986,"eighty":-0.749053,"marketCap":21971063},{"date":"2025-07-11","current":-0.364995,"twenty":-12.321805,"median":-1.376263,"eighty":-0.736735,"marketCap":22584453},{"date":"2025-07-18","current":-0.34989,"twenty":-12.208688,"median":-1.371276,"eighty":-0.726208,"marketCap":21649763},{"date":"2025-07-25","current":-0.355932,"twenty":-12.086803,"median":-1.362526,"eighty":-0.714584,"marketCap":22023639},{"date":"2025-08-01","current":-0.339032,"twenty":-11.971056,"median":-1.348984,"eighty":-0.704604,"marketCap":20977954},{"date":"2025-08-08","current":-0.35867,"twenty":-11.840107,"median":-1.344896,"eighty":-0.694375,"marketCap":22193052},{"date":"2025-08-15","current":-0.359246,"twenty":-11.771224,"median":-1.34011,"eighty":-0.682259,"marketCap":21380530},{"date":"2025-08-22","current":-0.352833,"twenty":-11.668535,"median":-1.334151,"eighty":-0.676845,"marketCap":20998839},{"date":"2025-08-29","current":-0.414401,"twenty":-11.597084,"median":-1.326748,"eighty":-0.665295,"marketCap":24663066},{"date":"2025-09-05","current":-0.492249,"twenty":-11.574286,"median":-1.320632,"eighty":-0.656505,"marketCap":29296200},{"date":"2025-09-12","current":-0.76378,"twenty":-11.495659,"median":-1.314366,"eighty":-0.65477,"marketCap":45456381},{"date":"2025-09-19","current":-0.681788,"twenty":-11.411542,"median":-1.304512,"eighty":-0.656505,"marketCap":40576617},{"date":"2025-09-26","current":-0.621503,"twenty":-11.372377,"median":-1.299375,"eighty":-0.645656,"marketCap":36988728},{"date":"2025-10-03","current":-0.653865,"twenty":-11.098213,"median":-1.294069,"eighty":-0.646279,"marketCap":38914796},{"date":"2025-10-10","current":-1.006402,"twenty":-10.738216,"median":-1.284214,"eighty":-0.649819,"marketCap":59896019},{"date":"2025-10-17","current":-0.726484,"twenty":-10.644884,"median":-1.277647,"eighty":-0.653782,"marketCap":43236705},{"date":"2025-10-24","current":-0.708329,"twenty":-10.538219,"median":-1.277647,"eighty":-0.650021,"marketCap":42156228},{"date":"2025-10-31","current":-0.685537,"twenty":-10.414053,"median":-1.273301,"eighty":-0.653782,"marketCap":40799759},{"date":"2025-11-07","current":-0.631764,"twenty":-10.12239,"median":-1.266219,"eighty":-0.650021,"marketCap":37599432},{"date":"2025-11-14","current":-0.650905,"twenty":-9.894892,"median":-1.265267,"eighty":-0.648893,"marketCap":38738631}],"updateTime":1763397268309},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCAB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583656209","title":"BioAtla’s Strategic Advancements and Promising Clinical Data Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2583656209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583656209?lang=en_us&edition=fundamental","pubTime":"2025-11-16 01:25","pubTimestamp":1763227541,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Justin Zelin from BTIG maintained a Buy rating on BioAtla, with a price target of $10.00. Justin Zelin has given hi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bioatlas-strategic-advancements-and-promising-clinical-data-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bioatlas-strategic-advancements-and-promising-clinical-data-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCAB"],"gpt_icon":0},{"id":"2583512213","title":"BioAtla Q3 net loss widens to $15.8 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512213","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512213?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:33","pubTimestamp":1763069591,"startTime":"0","endTime":"0","summary":"BioAtla Q3 net loss widens to $15.8 mlnOverviewBioAtla Q3 net loss widens to $15.8 mln, driven by absence of collaboration revenueR&D expenses decreased due to program prioritization and workforce red","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP18Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2583451490","title":"BioAtla Q3 EPS $(0.27) Beats $(0.30) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583451490","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583451490?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:10","pubTimestamp":1763068234,"startTime":"0","endTime":"0","summary":"BioAtla (NASDAQ:BCAB) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.30) by 9.09 percent. This is a 22.73 percent decrease over losses of $(0.22) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48850304/bioatla-q3-eps-0-27-beats-0-30-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioAtla Q3 EPS $(0.27) Beats $(0.30) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB"],"gpt_icon":0},{"id":"2583110165","title":"BRIEF-BioAtla Q3 Net Income USD -15.778 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583110165","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583110165?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067952,"startTime":"0","endTime":"0","summary":"BRIEF-BioAtla Q3 Net Income USD -15.778 Million\n\n\nNov 13 (Reuters) - BioAtla Q3 operating income USD -13.789 million.\n\nQ3 operating expenses USD 13.789 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX5D8788:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2581747886","title":"BioAtla announces data on Mecbotamab Vedotin","url":"https://stock-news.laohu8.com/highlight/detail?id=2581747886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581747886?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:10","pubTimestamp":1762524613,"startTime":"0","endTime":"0","summary":"BioAtla (BCAB) announced clinical data in a poster titled “Median OS of 21.5 months among 44 patients with treatment-refractory leiomyosarcoma, lip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioatla-announces-data-on-mecbotamab-vedotin-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioatla-announces-data-on-mecbotamab-vedotin-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","BCAB","OS","BK4139"],"gpt_icon":0},{"id":"2581886625","title":"BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2581886625","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581886625?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:00","pubTimestamp":1762524000,"startTime":"0","endTime":"0","summary":"— Mec-V demonstrates median OS of 21.5 months in patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma compared with approximately 12 months with app","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183685/0/en/BioAtla-s-Mecbotamab-Vedotin-Mec-V-an-AXL-targeting-ADC-Demonstrates-a-Median-Overall-Survival-OS-of-21-5-months-in-Subtypes-of-Refractory-Soft-Tissue-Sarcomas.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4080","BCAB","OS","BK4097","AXL","ADC","SITC","BK4124","BK4231"],"gpt_icon":0},{"id":"2581720644","title":"BioAtla to Announce Third Quarter 2025 Financial Results and Provide Business Highlights on November 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581720644","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581720644?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:00","pubTimestamp":1762347600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov.  05, 2025  (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/05/3181399/0/en/BioAtla-to-Announce-Third-Quarter-2025-Financial-Results-and-Provide-Business-Highlights-on-November-13-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2580542227","title":"Bioatla Inc  expected to post a loss of 30 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580542227","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580542227?lang=en_us&edition=fundamental","pubTime":"2025-11-04 07:54","pubTimestamp":1762214043,"startTime":"0","endTime":"0","summary":"Bioatla Inc  expected to post a loss of30cents a share - Earnings Preview Bioatla Inc BCAB.OQ BCAB.O is expected to  show a fall in quarterly revenue when it reports  results on November 5 (estimated)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF2QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2577301025","title":"BioAtla announces presentation of poster on Oz-V in OPSCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2577301025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577301025?lang=en_us&edition=fundamental","pubTime":"2025-10-23 20:20","pubTimestamp":1761222039,"startTime":"0","endTime":"0","summary":"BioAtla (BCAB) announced presentation of a poster entitled “Targeting HPV E6/E7 Upregulation of the Transmembrane Receptor Tyrosine Kinase ROR2 wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioatla-announces-presentation-of-poster-on-oz-v-in-opscc-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioatla-announces-presentation-of-poster-on-oz-v-in-opscc-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2577330907","title":"BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society","url":"https://stock-news.laohu8.com/highlight/detail?id=2577330907","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577330907?lang=en_us&edition=fundamental","pubTime":"2025-10-23 20:00","pubTimestamp":1761220800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct.  23, 2025  (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3172001/0/en/BioAtla-Presents-Compelling-Mechanistic-Rationale-for-Targeting-ROR2-with-Ozuriftamab-Vedotin-Oz-V-in-Oropharyngeal-Squamous-Cell-Carcinoma-OPSCC-at-the-Annual-Conference-of-the-In.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB","ADC","BK4231","ORR","OS","BK4097","BK4139","BK4080"],"gpt_icon":0},{"id":"2576527448","title":"BioAtla Says Cancer Therapy Showed 'Preliminary Prolonged Tumor Control' in Phase 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2576527448","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576527448?lang=en_us&edition=fundamental","pubTime":"2025-10-20 21:15","pubTimestamp":1760966138,"startTime":"0","endTime":"0","summary":"BioAtla  said Monday its cancer therapy BA3182 showed \"encouraging preliminary prolonged tumor control\" in a first-in-human phase 1 study.The therapy targets a tumor cell often present in adenocarcinomas of the colon, stomach, pancreas, biliary tract, lung, breast, prostate, and thyroid, the company said.Chief Executive Jay M. Short also said the therapy showed \"a manageable safety profile\" in the 35-patient study.Shares of the company were down 13% in recent premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2576513808","title":"BRIEF-BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576513808","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576513808?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:18","pubTimestamp":1760962733,"startTime":"0","endTime":"0","summary":"BRIEF-BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025Oct 20 (Reuters) - Bioatla Inc BCAB.O:BIOAT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUA7NFD8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2576851957","title":"BioAtla announces preliminary data from Phase 1 study of BA3182","url":"https://stock-news.laohu8.com/highlight/detail?id=2576851957","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576851957?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:15","pubTimestamp":1760962554,"startTime":"0","endTime":"0","summary":"BioAtla (BCAB) announced preliminary clinical data from a Phase 1 study of BA3182 during a poster presentation titled “Preliminary Results from a F...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioatla-announces-preliminary-data-from-phase-1-study-of-ba3182-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioatla-announces-preliminary-data-from-phase-1-study-of-ba3182-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2576859542","title":"Bioatla Presents Promising Interim Data From Its Phase 1 Trial With Ba3182 in Patients With Treatment Refractory Metastatic Adenocarcinoma at Esmo 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859542?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUA7NFD8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2572500920","title":"BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2572500920","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572500920?lang=en_us&edition=fundamental","pubTime":"2025-10-03 21:00","pubTimestamp":1759496400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct.  03, 2025  (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/03/3160967/0/en/BioAtla-to-Present-Clinical-Data-for-Mecbotamab-Vedotin-BA3011-in-Soft-Tissue-Sarcoma-at-SITC-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1103","BK4231","SITC","BCAB","BK4080","SG9999011746.SGD","BK4139","IE00B12V2V27.USD","01308","IE00BYQNZ168.SGD","IE00BYTNYN87.SGD","ADC","BK1541"],"gpt_icon":0},{"id":"2569675711","title":"BioAtla Inc. Granted Continued Nasdaq Listing with Conditions; Must Meet Equity and Bid Price Requirements by Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2569675711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569675711?lang=en_us&edition=fundamental","pubTime":"2025-09-23 23:25","pubTimestamp":1758641140,"startTime":"0","endTime":"0","summary":"BioAtla Inc. is undergoing an ongoing delisting process from The Nasdaq Stock Market due to not meeting specific minimum requirements. The company presented a compliance plan to Nasdaq's Hearing Panel on September 9, 2025, outlining steps to regain compliance. The Panel granted BioAtla's request for continued listing, contingent on meeting certain conditions. BioAtla has already applied to transfer to The Nasdaq Capital Market as of September 18, 2025. The company aims to meet the necessary stockholder equity and bid price criteria by December 31, 2025, and February 2, 2026, respectively.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioAtla Inc. published the original content used to generate this news brief via EDGAR, the Electronic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL4zjn09:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2565686028","title":"BRIEF-BioAtla Updates FDA on Ozuriftamab Vedotin Plan for OPSCC After Positive Phase 2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2565686028","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565686028?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:02","pubTimestamp":1757332928,"startTime":"0","endTime":"0","summary":"BRIEF-BioAtla Updates FDA on Ozuriftamab Vedotin Plan for OPSCC After Positive Phase 2 ResultsSept 8 (Reuters) - Bioatla Inc BCAB.O:BIOATLA ANNOUNCES REGULATORY UPDATE ON CLINICAL DEVELOPMENT PLAN FOR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUAG04QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2565205689","title":"BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Following Productive Type B (End of Phase 2) Meeting with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2565205689","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565205689?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:00","pubTimestamp":1757332800,"startTime":"0","endTime":"0","summary":"FDA alignment on Phase 3 ozuriftamab vedotin (Oz-V) trial design, including dosing regimen and endpoints to support potential accelerated approvalCompany continues preparations for enabling initiation","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/08/3146058/0/en/BioAtla-Announces-Regulatory-Update-on-Clinical-Development-Plan-for-Ozuriftamab-Vedotin-in-Oropharyngeal-Squamous-Cell-Carcinoma-OPSCC-Following-Productive-Type-B-End-of-Phase-2-M.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB","BK4139","ORR","BK4097","OS"],"gpt_icon":0},{"id":"2557511223","title":"Bioatla Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557511223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557511223?lang=en_us&edition=fundamental","pubTime":"2025-08-08 11:52","pubTimestamp":1754625152,"startTime":"0","endTime":"0","summary":"Bioatla Inc reports results for the quarter ended June 30 - Earnings SummaryBioatla Inc BCAB.OQ reported a quarterly adjusted loss of 32 cents per share for the quarter ended June 30, higher than the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U00G5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB"],"gpt_icon":0},{"id":"2557304596","title":"BioAtla Q2 EPS $(0.32) Misses $(0.29) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557304596","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557304596?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:09","pubTimestamp":1754597378,"startTime":"0","endTime":"0","summary":"BioAtla (NASDAQ:BCAB) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.29) by 9.22 percent. This is a 27.27 percent increase over losses of $(0.44) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46979502/bioatla-q2-eps-0-32-misses-0-29-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}